Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II, Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma

NCT01425996 is registered in ClinicalTrials.gov with Taiwan Liposome Company as lead sponsor.

NCT NCT01425996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01425996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II, Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma
Lead sponsor
Taiwan Liposome Company
Phase
Phase 1/2
Overall status
Terminated
Start date
October 27, 2011
Completion date
October 3, 2014
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular